These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 30232020)

  • 1. Quantitative Hepatic Fat Quantification in Non-alcoholic Fatty Liver Disease Using Ultrasound-Based Techniques: A Review of Literature and Their Diagnostic Performance.
    Ozturk A; Grajo JR; Gee MS; Benjamin A; Zubajlo RE; Thomenius KE; Anthony BW; Samir AE; Dhyani M
    Ultrasound Med Biol; 2018 Dec; 44(12):2461-2475. PubMed ID: 30232020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound-based hepatic fat quantification: current status and future directions.
    Seneviratne N; Fang C; Sidhu PS
    Clin Radiol; 2023 Mar; 78(3):187-200. PubMed ID: 36411088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative Evaluation of Hepatic Steatosis Using Advanced Imaging Techniques: Focusing on New Quantitative Ultrasound Techniques.
    Park J; Lee JM; Lee G; Jeon SK; Joo I
    Korean J Radiol; 2022 Jan; 23(1):13-29. PubMed ID: 34983091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative ultrasound approaches for diagnosis and monitoring hepatic steatosis in nonalcoholic fatty liver disease.
    Pirmoazen AM; Khurana A; El Kaffas A; Kamaya A
    Theranostics; 2020; 10(9):4277-4289. PubMed ID: 32226553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Pilot Comparative Study of Quantitative Ultrasound, Conventional Ultrasound, and MRI for Predicting Histology-Determined Steatosis Grade in Adult Nonalcoholic Fatty Liver Disease.
    Paige JS; Bernstein GS; Heba E; Costa EAC; Fereirra M; Wolfson T; Gamst AC; Valasek MA; Lin GY; Han A; Erdman JW; O'Brien WD; Andre MP; Loomba R; Sirlin CB
    AJR Am J Roentgenol; 2017 May; 208(5):W168-W177. PubMed ID: 28267360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease.
    Khov N; Sharma A; Riley TR
    World J Gastroenterol; 2014 Jun; 20(22):6821-5. PubMed ID: 24944472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound-based techniques for the diagnosis of liver steatosis.
    Ferraioli G; Soares Monteiro LB
    World J Gastroenterol; 2019 Oct; 25(40):6053-6062. PubMed ID: 31686762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound hepatic/renal ratio and hepatic attenuation rate for quantifying liver fat content.
    Zhang B; Ding F; Chen T; Xia LH; Qian J; Lv GY
    World J Gastroenterol; 2014 Dec; 20(47):17985-92. PubMed ID: 25548498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considerations of Ultrasound Scanning Approaches in Non-alcoholic Fatty Liver Disease Assessment through Acoustic Structure Quantification.
    Lin YH; Wan YL; Tai DI; Tseng JH; Wang CY; Tsai YW; Lin YR; Chang TY; Tsui PH
    Ultrasound Med Biol; 2019 Aug; 45(8):1955-1969. PubMed ID: 31130411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasonic Sound Speed Estimation for Liver Fat Quantification: A Review by the AIUM-RSNA QIBA Pulse-Echo Quantitative Ultrasound Initiative.
    Wang X; Bamber JC; Esquivel-Sirvent R; Ormachea J; Sidhu PS; Thomenius KE; Schoen S; Rosenzweig S; Pierce TT
    Ultrasound Med Biol; 2023 Nov; 49(11):2327-2335. PubMed ID: 37550173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiologic evaluation of nonalcoholic fatty liver disease.
    Lee SS; Park SH
    World J Gastroenterol; 2014 Jun; 20(23):7392-402. PubMed ID: 24966609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of Liver Fat Content with Ultrasound: A WFUMB Position Paper.
    Ferraioli G; Berzigotti A; Barr RG; Choi BI; Cui XW; Dong Y; Gilja OH; Lee JY; Lee DH; Moriyasu F; Piscaglia F; Sugimoto K; Wong GL; Wong VW; Dietrich CF
    Ultrasound Med Biol; 2021 Oct; 47(10):2803-2820. PubMed ID: 34284932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective comparison of three ultrasound-based techniques in quantitative diagnosis of hepatic steatosis in NAFLD.
    Zhu Y; Yin H; Zhou D; Zhao Q; Wang K; Fan Y; Chen K; Han H; Xu H
    Abdom Radiol (NY); 2024 Jan; 49(1):81-92. PubMed ID: 37950767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research Progress of Quantitative Ultrasound Assessment of Liver Steatosis in Non-alcoholic Fatty Liver Disease].
    Chen J; Zhang B
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Oct; 43(5):827-832. PubMed ID: 34728047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification.
    Lee DH
    Clin Mol Hepatol; 2017 Dec; 23(4):290-301. PubMed ID: 28994271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive evaluation of liver steatosis with imaging modalities: New techniques and applications.
    Zeng KY; Bao WY; Wang YH; Liao M; Yang J; Huang JY; Lu Q
    World J Gastroenterol; 2023 May; 29(17):2534-2550. PubMed ID: 37213404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review and economic evaluation.
    Bresnahan R; Duarte R; Mahon J; Beale S; Chaplin M; Bhattacharyya D; Houten R; Edwards K; Nevitt S; Maden M; Boland A
    Health Technol Assess; 2023 Jul; 27(10):1-115. PubMed ID: 37839810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Performance Comparison Between Ultrasound Attenuation Measurements From Right and Left Hepatic Lobes for Steatosis Detection in Non-alcoholic Fatty Liver Disease.
    Torkzaban M; Wessner CE; Halegoua-DeMarzio D; Rodgers SK; Lyshchik A; Nam K
    Acad Radiol; 2023 Sep; 30(9):1838-1845. PubMed ID: 36586759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the controlled attenuation parameter using FibroScan and attenuation imaging with ultrasound as a novel measurement for liver steatosis.
    Hsu PK; Wu LS; Su WW; Su PY; Chen YY; Hsu YC; Yen HH; Wu CL
    PLoS One; 2021; 16(10):e0254892. PubMed ID: 34653177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity.
    Pavlides M; Banerjee R; Tunnicliffe EM; Kelly C; Collier J; Wang LM; Fleming KA; Cobbold JF; Robson MD; Neubauer S; Barnes E
    Liver Int; 2017 Jul; 37(7):1065-1073. PubMed ID: 27778429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.